Pancreatic Cancer Research

ResearcherUniversity of RochesterNo recent work listed

Alexa D. Melucci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5594-5680; OpenAlex author ID A5035628774. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2022: 2 papers

Papers 2

  1. The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12497-x↗
  2. ASO Author Reflections: Pretreatment CA 19-9 Threshold of 98 U/mL is a Reasonable Cutoff for Prognostication of Clinical Stage I and II Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12541-w↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mihir Maheshkumar Shah · 2 shared papers, 2022 · strength 0.41
  2. Darren R. Carpizo · 2 shared papers, 2022 · strength 0.41
  3. David A. Kooby · 1 shared paper, 2022 · strength 0.15
  4. Anthony Casabianca · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.